Francisco Ivanildo DE Oliveira Junior

Francisco Ivanildo DE Oliveira Junior

Auto-generated profile, based on publicly available information

Francisco Ivanildo DE Oliveira Junior

Hospital Infantil Sabará, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
PDF file
ARAnna Clara Rabha
Anna Clara Rabha
FJFrancisco Ivanildo de Oliveira Junior
Francisco Ivanildo de Oliveira Junior
TOThales Araújo de Oliveira
Thales Araújo de Oliveira
RCRegina Grigolli Cesar
Regina Grigolli Cesar
GFGiuliana Fongaro
Giuliana Fongaro
GWGustavo Wandalsen
Gustavo Wandalsen
Objective: To describe the clinical manifestations and severity of children and adolescents affected by COVID-19 treated at Sabará Hospital Infantil. Methods: This is a cross-sectional, retrospective, and observational study. All cases of COVID-19 confirmed by RT-qPCR of patients seen at the hospital (emergency room, first-aid room, and ICU) were analyzed. The severity of the cases was classified according to the Chinese Consensus. Results: Among the 115 children included, a predominance of boys (57%) was verified, and the median age was two years. A total of 22 children were hospitalized, 12 in the ICU. Of the total, 26% had comorbidities with a predominance of asthma (13%). Fever, cough, and nasal discharge were the most frequent symptoms. Respiratory symptoms were reported by 58% of children and gastrointestinal symptoms, by 34%. Three children were asymptomatic, 81 (70%) had upper airway symptoms, 15 (13%) had mild pneumonia, and 16 (14%) had severe pneumonia. Hospitalized children were younger than non-hospitalized children (7 months vs. 36 months). In hospitalized patients, a higher frequency of irritability, dyspnea, drowsiness, respiratory distress, low oxygen saturation, and hepatomegaly was observed. Chest radiography was performed in 69 children with 45% of abnormal exams. No child required mechanical ventilation and there were no deaths. Conclusions: Most of children and adolescents affected by COVID-19 had mild upper airway symptoms. Clinical manifestations of COVID-19 were more severe among younger children who exhibited gastrointestinal and respiratory symptoms more frequently.

15 December 2022 in IJID Regions
Verified
Journal Article
Open access
DJDaniel Jarovsky
Daniel Jarovsky
GFGiuliana de Freitas Fongaro
Giuliana de Freitas Fongaro
RZRenata Mazzotti Zampol
Renata Mazzotti Zampol
TOThales Araújo de Oliveira
Thales Araújo de Oliveira
CFCamila Giuliana Almeida Farias
Camila Giuliana Almeida Farias
MSMarco Aurelio Palazzi Safadi
Marco Aurelio Palazzi Safadi
In 2020, Brazil became the epicentre of the coronavirus disease (COVID-19) pandemic in Latin America, resulting in an unparalleled health catastrophe. Nevertheless, comprehensive clinical reports in Brazilian children are not available. This retrospective, hospital-based, active surveillance study was performed to identify paediatric patients with COVID-19 who presented at a private academic medical centre in a large urban area between March 2020 and March 2021. Clinical and demographic information was analysed for those requiring hospitalization, those with severe illness and those with clinical syndromes. In total, 964 symptomatic cases were evaluated; of these, 17.7% required hospitalization, and 27.5% of hospitalized cases were classified as severe/critical. Acute bronchiolitis and pneumonia were the most common causes of hospitalization among the severe cases. Twenty-seven hospitalized children fulfilled the diagnostic criteria for multi-system inflammatory syndrome (median age 29 months; 85.2% cases were non-severe). A significant co-existing condition was present in 29% of hospitalized children. The risk of hospitalization was higher in children with at least one comorbidity, children aged <2 years and obese children. Increased risk of severe disease was described among those with leukopenia, leukocytosis or any significant comorbidity. No deaths occurred among the study population. Although most children with COVID-19 experienced mild disease, and no deaths occurred among the study population, a significant proportion of cases required hospitalization and developed severe illness. Obesity, young age, underlying comorbidity, leukopenia and leukocytosis were risk factors for hospitalization or severe disease.

24 September 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAline Benjamin
Aline Benjamin
SCSolange Cesar Cavalcante
Solange Cesar Cavalcante
LJLeda Fátima Jamal
Leda Fátima Jamal
DADenise Arakaki-Sanchez
Denise Arakaki-Sanchez
JLJosué Nazareno De Lima
Josué Nazareno De Lima
VRValeria Rolla
Valeria Rolla
Determine TB-LAM Ag (LAM) is a point of care test developed to diagnose tuberculosis (TB). The aim of this study was to evaluate the diagnostic performance of LAM in people living with HIV using Brazilian public health network algorithm for TB diagnosis. A cross-sectional study design was used to enroll 199 adult patients in two sites in Rio de Janeiro and two in São Paulo. The study enrolled HIV-infected patients with CD4 counts ≤200 cells/mm3 (in the Alere PIMA CD4 assay at study screening), patients coughing for at least 2 weeks or presenting a chest radiography suggestive of TB. LAM, in conjunction with sputum smear microscopy or Xpert MTB/RIF (Xpert) as compared to Mycobacterium tuberculosis culture, which was used as a reference standard. TB prevalence was 24.6%. Overall accuracy of LAM was 79.9% (73.8%-84.9%), positive and negative predictive values were 62.2% (46.1%-75.9%) and 84% (77.5%-88.8%), respectively. The overall LAM sensitivity was 46.9% (33.7%-60.6%) and specificity was 90.7% (84.9%-94.4%). The best performance of LAM was observed among patients with CD4 counts ≤50 cells/mm3 (sensitivity = 70.4% and specificity = 85.9%). When 2 respiratory smears were used in conjunction with LAM, sensitivity increased 22%, as compared to just 2 smears. Furthermore, LAM when used in conjunction with two respiratory smears, was as sensitive as compared to a single one. However, no improvement in TB diagnosis occurred when LAM was used with Xpert as compared to Xpert alone. Among 14 LAM false positive tests, Non-Tuberculosis Mycobacteria were isolated in three cases. LAM is a point of care test that increased TB diagnosis in immunosuppressed HIV-infected patients when used in conjunction with smear microscopy, but not when used with Xpert in Brazilian public health network sites. Use of LAM test should be considered in settings where immunosuppressed HIV patients need rapid TB diagnosis.

12 April 2023 in Mycoses
Verified
Journal Article
Closed access
VTVanessa Souza Santos Truda
Vanessa Souza Santos Truda
DFDiego Rodrigues Falci
Diego Rodrigues Falci
FPFátima Maria Venancio Porfírio
Fátima Maria Venancio Porfírio
DSDaniel Wagner de Castro Lima de Santos
Daniel Wagner de Castro Lima de Santos
FJFrancisco Ivanildo Oliveira Junior
Francisco Ivanildo Oliveira Junior
Arnaldo L. ColomboArnaldo L. Colombo
Arnaldo L. Colombo

1 January 2022 in Revista do Colégio Brasileiro de Cirurgiões
Verified
Journal Article
Open access
CSCezar Daniel Snak DE Souza
Cezar Daniel Snak DE Souza
TSTatiana Saruhashi
Tatiana Saruhashi
MLMariana Fontes Neville Lima
Mariana Fontes Neville Lima
FJFrancisco Ivanildo DE Oliveira Junior
Francisco Ivanildo DE Oliveira Junior
DCDebora DE Oliveira Cumino
Debora DE Oliveira Cumino
The novel coronavirus SARS-COV-2 (COVID-19) pandemic dramatically changed the workflow of healthcare professionals around the world. Surgical procedures were withheld and postponed in a scenario of fear and uncertainty. Despite numerous medical institutions having swiftly and widely implemented pre-operative screening protocols, cost-effective studies remain scarce specially when comparing to other mitigation measures such as the donning of masks and social distancing measures. The objective of our study is to report the monthly positivity rates of SARS-COV-2 infection in our service and compare our data with monthly positivity rates reported by the State Health Department. Between April, 2020, to February, 2022, 7,199 patients had the RT-PCR for SARS-COV-2 collected, with 187 (2.59%) testing positive for COVID-19. Most of them (62.1%) were asymptomatic. The most common symptoms were coryza (10.7%), fever (10%), and diarrhea (8.7%). Nonetheless, there were two deaths due to COVID-19 reported in our center. Further studies are necessary to elucidate the impact of pre-operative screening for SARS-COV-2 in asymptomatic patients.

1 January 2022 in Revista do Colégio Brasileiro de Cirurgiões
Verified
Journal Article
Open access
CSCezar Daniel Snak DE Souza
Cezar Daniel Snak DE Souza
TSTatiana Saruhashi
Tatiana Saruhashi
MLMariana Fontes Neville Lima
Mariana Fontes Neville Lima
FJFrancisco Ivanildo DE Oliveira Junior
Francisco Ivanildo DE Oliveira Junior
DCDebora DE Oliveira Cumino
Debora DE Oliveira Cumino
RESUMO A pandemia causada pelo novo coronavírus (SARS-COV-2) alterou a rotina de pacientes, profissionais e serviços de saúde em todo o mundo levando ao adiamento ou suspensão de muitos procedimentos cirúrgicos. Muitos serviços implementaram protocolos de triagem sistemática pré-operatória para SARS-COV-2. No entanto, segue incerta a eficácia da triagem sistemática de pacientes assintomáticos para SARS-COV-2 quando comparada com outras medidas de mitigação como o uso de máscaras e o distanciamento social apesar da aparente sensação de segurança conferida pela testagem pré-operatória de pacientes para SARS-COV-2. Sendo assim, descrevemos a experiência de dois anos de um hospital pediátrico (n=7.199) na triagem sistemática pré-operatória para SARS-COV-2 e comparamos a taxa de positividade mensal reportada pelo serviço em relação a taxa de positividade mensal regional do Estado de São Paulo. No período de Abril de 2020 a Fevereiro de 2022 houveram 187 (2,56%) RT-PCR positivos para COVID-19 dos quais 62.1% assintomáticos. Os sintomas mais comuns foram coriza (10,7%), febre (10%) e diarreia (8,7%). Dois pacientes faleceram em decorrência de sintomas relacionados a COVID-19. Mais estudos são necessários para determinar o impacto da testagem pré-operatória de RT-PCR para SARS-COV-2 em pacientes assintomáticos na mitigação da transmissão intra-hospitalar e na morbidade cirúrgica.